Skip to main content

Diffusion Pharmaceuticals, Inc. (DFFN)

NASDAQ: DFFN · IEX Real-Time Price · USD
0.504 -0.011 (-2.12%)
Sep 24, 2021 3:24 PM EDT - Market open
Market Cap52.48M
Revenue (ttm)n/a
Net Income (ttm)-16.92M
Shares Out101.90M
EPS (ttm)-0.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume409,650
Open0.515
Previous Close0.515
Day's Range0.500 - 0.519
52-Week Range0.464 - 1.850
Beta1.56
AnalystsHold
Price Target2.00 (+297.1%)
Est. Earnings DateNov 11, 2021

About DFFN

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

IndustryBiotechnology
Founded2001
Employees12
Stock ExchangeNASDAQ
Ticker SymbolDFFN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for DFFN stock is "Hold" and the 12-month stock price forecast is 2.00.

Price Target
$2.00
(297.14% upside)
Analyst Consensus: Hold

News

Diffusion Pharmaceuticals Issues Letter to Shareholders

CHARLOTTESVILLE, Va., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies ...

2 weeks ago - GlobeNewsWire

Diffusion Pharmaceuticals to Present at the 23rd Annual H.C. Wainwright Global Investment Conference

Conference to Take Place Virtually, September 13-15, 2021 Conference to Take Place Virtually, September 13-15, 2021

2 weeks ago - GlobeNewsWire

Diffusion Pharmaceuticals Announces Clearance of IND Application for TSC by FDA's Pulmonology, Allergy, and Critical ...

Phase 2 DLCO Trial in Interstitial Lung Disease Expected to Begin in Q4 Under New IND

3 weeks ago - GlobeNewsWire

Diffusion Pharmaceuticals Reports Q2 Financial Results and Provides Business Update

CHARLOTTESVILLE, Va., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies t...

1 month ago - GlobeNewsWire

Making a List of Penny Stocks to Buy? Here's 7 to Watch in Summer 2021

Does your list of penny stocks to watch include these 7 hot small-caps? The post Making a List of Penny Stocks to Buy?

2 months ago - PennyStocks

7 Trending Penny Stocks That You Need to Know About in July 2021

Are these trending penny stocks worth adding to your watchlist? The post 7 Trending Penny Stocks That You Need to Know About in July 2021 appeared first on Penny Stocks to Buy, Picks, News and Informati...

2 months ago - PennyStocks

Diffusion Pharma's TSC Shows Encouraging Effects On Oxygenation

Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) has announced topline results from the Phase 1 trial of its lead product candidate, trans sodium crocetinate (TSC). In the trial, transcutaneous oxygen monit...

2 months ago - Benzinga

Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial

Trial Dosed Healthy Volunteers with Trans Sodium Crocetinate Trial Dosed Healthy Volunteers with Trans Sodium Crocetinate

2 months ago - GlobeNewsWire

Diffusion Pharmaceuticals to Webcast Live at Life Sciences Investor Forum

Presentation Scheduled for June 24, 2021 at 11:30 a.m., EDT Presentation Scheduled for June 24, 2021 at 11:30 a.m., EDT

3 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Reminds Stockholders to Vote Shares In Advance of Annual Meeting

Annual Meeting Scheduled for June 25, 2021, at 1 p.m. EDT Annual Meeting Scheduled for June 25, 2021, at 1 p.m. EDT

3 months ago - GlobeNewsWire

Best Penny Stocks Today? 4 Small-Cap Stocks To Watch Under $1 In June

Hot Penny Stocks Under $1 To Watch This Month The post Best Penny Stocks Today? 4 Small-Cap Stocks To Watch Under $1 In June appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto...

Other symbols:JOB
3 months ago - PennyStocks

Diffusion Pharma's Trans Sodium Crocetinate Associated With Improved Outcomes In COVID-19 Patients

Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) has announced final results from the Phase 1b study evaluating trans sodium crocetinate (TSC) in hospitalized COVID-19 patients. Data from the open-label stu...

4 months ago - Benzinga

Diffusion Pharmaceuticals Reports Final Results from Its Phase 1b Study of Trans Sodium Crocetinate in Hospitalized C...

CHARLOTTESVILLE, Va., May 10, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies th...

4 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update

CHARLOTTESVILLE, Va., May 10, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies th...

4 months ago - GlobeNewsWire

Top Biotech Penny Stocks on Reddit? Check These 3 Out

Biotech penny stocks are back in focus; should these 3 be on your watchlist? The post Top Biotech Penny Stocks on Reddit?

Other symbols:AIKIATOS
4 months ago - PennyStocks

Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study

CHARLOTTESVILLE, Va., March 25, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies ...

5 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update

CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies ...

6 months ago - GlobeNewsWire

Diffusion Pharmaceuticals, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

CHARLOTTESVILLE, Va., March 04, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies ...

6 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock

CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies t...

7 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients

No Dose Limiting Toxicities or Serious Adverse Events Observed in Dosing Regimen Previously Untested in Clinical Trial Setting No Dose Limiting Toxicities or Serious Adverse Events Observed in Dosing Re...

7 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $30 Million

CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative clinical stage biopharmaceutical company developing no...

7 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock

CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative clinical stage biopharmaceutical company developing no...

7 months ago - GlobeNewsWire

Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference

CHARLOTTESVILLE, Va., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced that the Company is participating in the H.C. Wainwr...

8 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates

Initiated and Advanced C linical Trial Evaluating Lead Product Candidate in COVID-19 Patients

10 months ago - GlobeNewsWire

Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer

CHARLOTTESVILLE, Va., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced the appointment of Christopher D. Galloway, M.D. to ...

11 months ago - GlobeNewsWire